A federal judge in South Dakota has preliminarily enjoined enforcement of a state abortion-advertising restriction against a reproductive-health education nonprofit and an attorney, concluding the challengers are likely to succeed on their First Amendment claims. The ruling is another important entry in the growing body of post-Dobbs litigation testing how far states can go when regulating not just abortion procedures, but speech about abortion.

At this stage, the court did not finally decide the statute’s constitutionality.

The Justice Department has filed a proposed consent decree in the U.S. District Court for the District of Kansas to resolve alleged Clean Water Act violations arising from the 2022 Keystone Pipeline rupture in Kansas. The case targets the owner and operator of the pipeline system, now associated with South Bow, and centers on one of the most closely watched pipeline spill events in recent years.

According to the government, the settlement would address civil environmental claims tied to the rupture and the operator’s spill-response obligations.

The Patent Trial and Appeal Board’s July 14, 2026 institution decision in IPR2026-00276 granted inter partes review, finding that the petitioner made the required threshold showing that at least one challenged claim is reasonably likely to be unpatentable.

The Justice Department has agreed to pay $180 million to the Municipality of Anchorage to resolve a long-running dispute over the Port of Anchorage expansion project, bringing an end to litigation that began in 2014. The resolution closes out one of the more notable federal-liability infrastructure cases in recent years, both because of the size of the payment and because it centers on alleged failures tied to a major public works project.

The underlying case, ANCHORAGE, A MUNICIPAL CORPORATION v. USA, has been closely watched by lawyers handling claims involving federal project participation, municipal plaintiffs, and damages arising from large-scale construction and engineering failures.

The Justice Department’s sentencing of a former adviser to the Federal Reserve Board of Governors is one of the clearest recent reminders that insider-trading exposure is not limited to public-company executives, bankers, or hedge funds. It also reaches government and quasi-government insiders who misuse market-sensitive information obtained through positions of trust.

According to the government’s announcement, the former Fed adviser received a federal prison sentence after being prosecuted for exploiting confidential economic information.

A federal judge in the Southern District of Florida has blocked a proposed settlement in President Donald Trump’s lawsuit against the IRS and the Treasury Department, finding the case was pursued for an “improper purpose” and referring the lawyers involved for possible disciplinary review.

A federal judge in Miami has thrown out a purported settlement between President Donald Trump and the IRS, finding that the underlying lawsuit was brought in bad faith and that the agreement cannot be relied on in future proceedings. In the same order, U.S. District Judge Kathleen Williams reportedly referred the lawyers involved to disciplinary authorities—an unusually sharp response that raises the stakes well beyond the immediate dispute.

The ruling is notable for two reasons.

I’m missing the underlying news story needed to write the post as requested.

Your prompt refers to a “specific legal news story” and mentions broadening it to the past 7 days with a strong 6–8 item list, but no story details, case names, court filings, party names, jurisdiction, or Docket Alarm links were included.

To produce the blog post in the format you want, please send any of the following:

• the headline or summary of the legal news story,
• the parties and court,
• the docket or case number,
• any Docket Alarm case links you want woven in, and/or
• the 6–8 related developments from the past 7 days you want included.

Once you provide that, I can turn it around into a 300–500 word HTML post with:

• a concise, story-specific title,
• clear explanation of the legal significance,
• practical context for litigators, in-house counsel, and compliance teams, and
• natural integration of any Docket Alarm links you supply.

A federal judge in Washington has delivered an unusually sharp rebuke in litigation tied to President Donald Trump, ruling that a $10 billion lawsuit against the Internal Revenue Service was brought for an improper purpose and appeared aimed at giving legal cover to a settlement that would grant special benefits to Trump-affiliated parties.

The ruling goes beyond dismissal or adverse merits findings.

The Department of Justice has unveiled one of the year’s largest coordinated health care enforcement actions: the 2026 National Health Care Fraud Takedown, which includes charges against 455 defendants nationwide, among them 90 physicians and other licensed professionals. Prosecutors say the cases involve more than $6.5 billion in alleged false claims, underscoring the scale of the government’s continuing focus on fraud in federal health care programs.

The sweep was coordinated across U.S. Attorneys’ Offices, with participation from DOJ’s Criminal Division, HHS-OIG, CMS, and other federal and state enforcement partners.

The Tenth Circuit’s July 13, 2026 opinion in No. 25-3092 is a useful reminder that appellate outcomes often turn as much on procedure as on merits. Although the docket entry is styled simply as an “Opinion,” the court’s analysis focuses on the threshold question of whether the appeal was properly before it and what constitutes an appealable decision under federal practice.

At bottom, the court addressed whether the order being challenged satisfied the requirements for appellate review under the final-judgment rule, and whether any exception permitted immediate review.

The biggest challenge in assessing the July 17–18 legal news cycle is that several high-impact developments are unfolding at once across courts, enforcement, and criminal matters. For legal professionals, the takeaway is less about any single headline and more about the cumulative signal: agencies, prosecutors, and courts continue to move aggressively on matters with enterprise-wide risk implications.

That matters because legal departments are being asked to respond faster to overlapping threats.

The Justice Department has agreed to pay the Municipality of Anchorage $180 million to resolve long-running litigation over the failed Port of Anchorage expansion project, closing out a dispute that has been pending for more than a decade. For public-law watchers and federal litigators, the settlement stands out both for its size and for the age of the case, which traces back to a 2014 filing in the Court of Federal Claims.

The underlying lawsuit, ANCHORAGE, A MUNICIPAL CORPORATION v. USA, arose from an expansion effort at the Port of Anchorage that ultimately failed, leaving behind years of litigation over responsibility for the project’s breakdown and the resulting financial harm.

The U.S. Department of Justice has told New Mexico officials it cannot legally turn over unredacted Jeffrey Epstein-related files sought for a state investigation into conduct tied to Epstein’s former ranch in New Mexico. The request, made by state officials pursuing their own live probe, has now developed into a notable federal-state dispute over how far cooperation can go when court-imposed confidentiality protections and victim privacy concerns remain in force.

At the center of the clash is a familiar but difficult issue: when one sovereign is investigating possible criminal conduct, what limits apply to evidence gathered or held by another? DOJ’s position appears to be that existing legal constraints — including protective orders, privacy obligations to victims and witnesses, and restrictions on investigative materials — prevent disclosure of the files in the form New Mexico wants.

The FTC has announced a significant settlement with Caremark Rx LLC and Zinc Health Services LLC in its insulin-pricing antitrust matter, marking one of the clearest signals yet that pharmacy benefit manager rebate structures remain a top enforcement priority. According to the agency, the deal is designed to reduce patients’ out-of-pocket costs, increase transparency, and curb rebate practices that allegedly contributed to higher insulin list prices.

The proceeding, Caremark Rx, Zinc Health Services, et al., In the Matter of (Insulin), is part of the FTC’s broader challenge to how major drug middlemen negotiate formularies, rebates, and placement decisions for high-demand medications.